Press Releases
GNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer
CAMBRIDGE, Mass.– October 3, 2018 – GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in...
read moreClinical and Machine Learning Expert, Dr. Ziad Obermeyer Joins GNS Healthcare’s Strategic Advisory Board
CAMBRIDGE, Mass.– September 18, 2018 – GNS Healthcare (GNS), a leading precision medicine company, today announced the appointment of Ziad Obermeyer, MD, Associate Professor of Health Policy and Management at the UC Berkeley School of Public Health, to its strategic...
read moreCross-Industry Collaboration of GNS Healthcare, Amgen and Alliance for Clinical Trials in Oncology to Leverage AI to Advance Understanding of Treatment Response in Metastatic Colorectal Cancer
Collaboration to apply causal artificial intelligence and clinical trial data to identify factors that drive treatment response in patients with metastatic colorectal cancer
read moreGNS Healthcare Taps Technology Leader as CTO to Drive Productization of Causal AI Platform
CAMBRIDGE, Mass.– August 22, 2018 – GNS Healthcare (GNS), a leading precision medicine company, announced the hiring of veteran software executive Scott McKay as Chief Technology Officer. McKay brings over 25 years of hands-on experience in software development,...
read moreThe ALS Association Partners with GNS Healthcare to Apply AI to Accelerate Answer ALS Research
GNS Healthcare to combine its powerful, causal machine learning technology with the comprehensive Answer ALS patient datasets
read moreSomaLogic Licenses GNS Healthcare’s REFS™ technology for analysis of its SOMAscan®- derived proteomic data
Combining the world-leading proteomic and artificial intelligence/machine learning technologies to produce novel, actionable health insights across many diseases, conditions and markets
read moreGNS Healthcare and Alliance for Clinical Trials in Oncology Present Results of Causal Modeling that Identifies Clinical and Molecular Drivers of Survival in Colorectal Cancer Patients
Results presented at ASCO 2018 Annual Meeting in Chicago show drivers at baseline allow better risk stratification at initiation of treatment
read moreGNS Healthcare Names Ted Goldstein, Silicon Valley Tech Innovator and Scientific Program Director of Computational Health at UCSF to its Strategic Advisory Board
CAMBRIDGE, Mass.–May 31, 2018 – GNS Healthcare (GNS), a leading precision medicine company, announced the appointment of Dr. Ted Goldstein, Scientific Program Director of Computational Health of University of California, San Francisco, to its Strategic Advisory Board...
read moreGNS Healthcare to Present Results on Prediction of Disease Progression Using AI in NASH Patients at The International Liver Congress™
CAMBRIDGE, Mass.– April 13, 2018– GNS Healthcare (GNS), a leading precision medicine company, will present results from a recent study on Friday, April 13th at the International Liver Congress™ 2018 in Paris. The analysis focused on the progression of Nonalcoholic...
read moreGNS Healthcare Names Patrick Getzen, Chief Data and Analytics Officer of Blue Cross and Blue Shield of North Carolina, to its Strategic Advisory Board
CAMBRIDGE, Mass.– February 6, 2018 – GNS Healthcare (GNS), a leading precision medicine company, announced the appointment of Patrick Getzen, Chief Data and Analytics Officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC), to its Strategic Advisory...
read more